The flow cytometry-based assay measures the expression of the protein FcyR11a as a biomarker for cardiovascular risk.

Chancellor tells the City she is “clear that the financial services sector must play a central part in our economic vision ...

The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...

Primary care clinicians and practices are uniquely positioned to help people achieve optimal cardiovascular health through screening, diagnosing and treating the health behaviors and factors outlined ...